DLA Piper's Schulman Joins Pfizer As GC

Law360, New York (May 28, 2008, 12:00 AM EDT) -- Amy Schulman, who was the lead attorney for Pfizer Inc. in the Celebrex and Bextra multidistrict litigation when she was a partner at DLA Piper, has left the firm to take the top legal job at Pfizer.

Schulman will join Pfizer as a general counsel and senior vice president, the company announced Wednesday. She will begin work on June 23 and will replace Allen Waxman, who left the company in March for personal reasons.

“We know firsthand the outstanding qualities that Amy brings to us,” Jeffrey...
To view the full article, register now.